The Challenge of Change - Managing Excipients Control
Colorcon
24-Aug-2011 - The UAE needs overseas investment to kick-start its pharmaceutical manufacturing sector and end reliance on foreign imports, the DCCI says.
23-Aug-2011 - Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
22-Aug-2011 - Contract speciality chemical maker Chemspec International says it will ‘go private’ after being taken over by Halogen Limited, a holding company co-owned by members of its management board.
22-Aug-2011 - Vapotherm’s Precision Flow system for the conditioning of breathing gases has received the FDA thumbs up for the administration of nitric oxide via high flow nasal cannula.
22-Aug-2011 - in-PharmaTechnologist presents a roundup of recent ingredient and formulation research, including improved API impurity detection and a simple step to boost stability.
18-Aug-2011 - The generic drug industry and the US FDA have reached an agreement that would see the former fund the latter’s overseas facility inspection programme to the tune of $299m a year, according to a number of reports.
17-Aug-2011 - Intersect have received the FDA seal of approval of their targeted drug delivery technology for treatment in chronic sinusitis patients.
17-Aug-2011 - Encap Drug Delivery now offers a ‘feasibility package’ to assess the potential of its Phoral coating technology as a vehicle for therapy in colonic diseases.
17-Aug-2011 - in-PharmaTechnologist presents a roundup of recent drug delivery research, including a pH activated capsule and plant-based administration.
16-Aug-2011 - Surging anti-viral sales drove fine chemical growth at Ampac in Q3, but the unit posted a loss after missing efficiency and throughput targets.
11-Aug-2011 - A new review paper warning manufacturers about the dangers of under-estimating the effects of excipients has received the thumbs up from IPEC.
10-Aug-2011 - Tereos Syral plans to add pyrogen-controlled glucose monohydrate production capacity to expand into pharmaceutical starch derivatives.
10-Aug-2011 - Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.
09-Aug-2011 - Gilead Sciences is to buy a 70,000 sq ft clinical scale biologics production plant in California from Genentech.
09-Aug-2011 - AstraZeneca has collaborated to research a scalable system based on inkjet printing for formulating personalised medicines.
08-Aug-2011 - International Chemical Investors Group (ICIG) will take over Roche’s Colorado API plant in a bid to gain footing in the peptide manufacturing industry.
08-Aug-2011 - Neuland Laboratories posted a first quarter profit after API sales and peptide synthesis drove double-digit revenue growth.
04-Aug-2011 - The final results of the US FDA, EMA, TGA joint manufacturing facility inspection programme will make for interesting reading for API producers as they strongly hint the approach is here to stay.
04-Aug-2011 - Shares in Cambrex soared 30 per cent after custom manufacturing and generic API sales drove revenue growth.
04-Aug-2011 - Stellar Biotechnologies is supplying SAFC with an intermediate derived from limpets to support production of cancer vaccines.
04-Aug-2011 - FMC plans to add controlled release technologies and expand excipient production to drive growth at its BioPolymer unit.
03-Aug-2011 - The EDQM will work to improve the quality of traditional Chinese medicines (TCM) sold in Europe under a memorandum of understanding (MoU) with SATCM.
02-Aug-2011 - The EDQM has suggested Google Earth as a potential source of GPS co-ordinate data for manufacturing sites that must be supplied in CEP applications under recently introduced requirements.
02-Aug-2011 - OctoPlus is targeting specialty generics manufacturers it believes can benefit from its controlled release drug delivery technologies.
28-Jul-2011 - Fujifilm is to strengthen its API and formulations business by forming a Japan-focused joint venture with Dr Reddy’s.